SESTI, Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 2.368
AS - Asia 1.803
EU - Europa 1.014
SA - Sud America 461
AF - Africa 47
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.706
Nazione #
US - Stati Uniti d'America 2.296
SG - Singapore 854
IT - Italia 430
BR - Brasile 354
CN - Cina 329
VN - Vietnam 241
DE - Germania 214
IN - India 161
FI - Finlandia 100
GB - Regno Unito 82
HK - Hong Kong 56
AR - Argentina 47
CA - Canada 39
SE - Svezia 33
PL - Polonia 30
BD - Bangladesh 25
NL - Olanda 23
IQ - Iraq 22
MX - Messico 20
ID - Indonesia 18
TR - Turchia 17
EC - Ecuador 16
ES - Italia 16
ZA - Sudafrica 16
FR - Francia 14
RU - Federazione Russa 12
VE - Venezuela 12
EE - Estonia 11
JP - Giappone 11
CL - Cile 10
CZ - Repubblica Ceca 10
UA - Ucraina 10
PK - Pakistan 9
AU - Australia 8
IL - Israele 8
KE - Kenya 8
MT - Malta 8
CO - Colombia 7
JO - Giordania 7
SA - Arabia Saudita 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
IR - Iran 6
EG - Egitto 5
AT - Austria 4
BG - Bulgaria 4
MA - Marocco 4
MY - Malesia 4
PY - Paraguay 4
UZ - Uzbekistan 4
JM - Giamaica 3
PE - Perù 3
PH - Filippine 3
SN - Senegal 3
BY - Bielorussia 2
CR - Costa Rica 2
DZ - Algeria 2
EU - Europa 2
HN - Honduras 2
IE - Irlanda 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
NG - Nigeria 2
NI - Nicaragua 2
NP - Nepal 2
RO - Romania 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BE - Belgio 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CH - Svizzera 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
KG - Kirghizistan 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
NE - Niger 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PW - Palau 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TO - Tonga 1
TT - Trinidad e Tobago 1
Totale 5.706
Città #
San Jose 509
Singapore 363
Ashburn 246
Munich 187
Dallas 170
Santa Clara 150
Chandler 124
Bengaluru 123
Hefei 122
Ho Chi Minh City 97
Milan 92
Beijing 66
Chicago 62
Princeton 57
Hong Kong 55
Lawrence 55
London 51
Helsinki 49
Boardman 47
Hanoi 44
Los Angeles 44
Turku 42
Rome 33
New York 30
São Paulo 29
Wilmington 27
Catanzaro 26
Warsaw 25
Orem 16
Rio de Janeiro 15
Alessandria 14
Assago 14
Amsterdam 12
Atlanta 12
Brooklyn 12
Baghdad 11
Ottawa 11
Bari 10
Des Moines 10
Guarulhos 10
Naples 10
Olomouc 10
San Francisco 10
Tokyo 10
Da Nang 9
Montreal 9
Aversa 8
Chennai 8
Haiphong 8
Johannesburg 8
Messina 8
Curitiba 7
Guayaquil 7
Nairobi 7
Palermo 7
Salvador 7
St Louis 7
Amman 6
Biên Hòa 6
Boston 6
Campinas 6
Castrovillari 6
Charlotte 6
Cosenza 6
Council Bluffs 6
Denver 6
Hanover 6
Jyväskylä 6
Mexico City 6
Montevideo 6
Rende 6
Thái Bình 6
Belo Horizonte 5
Buffalo 5
Dhaka 5
Magé 5
Ninh Bình 5
Phoenix 5
Pune 5
Redmond 5
Rosario 5
San Nicola Manfredi 5
Teresina 5
Udine 5
Ankara 4
Buenos Aires 4
Can Tho 4
Cape Town 4
Carapicuíba 4
Columbus 4
Gustavo Adolfo Madero 4
Ha Long 4
Hortolândia 4
Huế 4
Indore 4
Istanbul 4
Manchester 4
Mumbai 4
Norwalk 4
Petaling Jaya 4
Totale 3.426
Nome #
Association between higher duodenal levels of the fructose carrier glucose transporter-5 and nonalcoholic fatty liver disease and liver fibrosis 201
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 118
Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: Data from an in vivo model 78
Depressed myocardial mechano-energetic efficiency in subjects with dysglycemia 76
Alkaline phosphatase affects renal function in never-treated hypertensive patients: effect modification by age 74
Uric acid and vascular damage in essential hypertension: Role of insulin resistance 74
Association between serum Mg2+ concentrations and cardiovascular organ damage in a cohort of adult subjects 72
Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis. 72
The TRIB3 R84 variant is associated with increased left ventricular mass in a sample of 2426 White individuals 70
Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis 69
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects 69
Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis 69
Are Circulating Mg2+ Levels Associated with Glucose Tolerance Profiles and Incident Type 2 Diabetes? 68
Depressed myocardial mechano-energetic efficiency in subjects with dysglycemia 68
Ferritin modifies the relationship between inflammation and arterial stiffness in hypertensive patients with different glucose tolerance 66
Chronic hyperglycemia impairs insulin secretion by affecting insulin receptor expression, splicing, and signaling in RIN beta cell line and human islets of Langerhans 65
Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis. 65
Effects of Sacubitril-Valsartan on Clinical, Echocardiographic, and Polygraphic Parameters in Patients Affected by Heart Failure With Reduced Ejection Fraction and Sleep Apnea 64
Short term effect of sacubitril/valsartan on comprehensive geriatric assessment in chronic heart failure: a real life analysis 63
One-hour post-load hyperglycemia combined with HbA1c identifies individuals with augmented duodenal levels of sodium/glucose co-transporter 1 63
Continuous Positive Airway Pressure Improves Renal Function in Obese Patients With Obstructive Sleep Apnea Syndrome 62
Sex-differences in insulin sensitivity and insulin secretion in subjects with impaired fasting glucose and impaired glucose tolerance 61
Neutrophil degranulation biomarkers characterize restrictive echocardiographic pattern with diastolic dysfunction in patients with diabetes 61
Immunity, Inflammation and Heart Failure: Their Role on Cardiac Function and Iron Status 60
Association between right ventricular dysfunction and adverse cardiac events in mild COPD patients 59
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 59
Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care 57
Sarcopenia and Appendicular Muscle Mass as Predictors of Impaired Fasting Glucose/Type 2 Diabetes in Elderly Women 56
International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes 55
Effects of 26 weeks of treatment with empagliflozin versus glimepiride on the myocardial glucose metabolic rate in patients with type 2 diabetes: The randomized, open-label, crossover, active-comparator FIORE trial 55
Reduction in Global Myocardial Glucose Metabolism in Subjects With 1-Hour Postload Hyperglycemia and Impaired Glucose Tolerance 55
HDL (High-Density Lipoprotein) and ApoA-1 Potentially Modulate Pancreatic α-Cell Glucagon Secretion 54
Glucagon induces the hepatic expression of inflammatory markers in vitro and in vivo 54
Obesity and overweight are linked to increased sodium-glucose cotransporter 1 and glucose transporter 5 levels in duodenum 53
HDL cholesterol is an independent predictor of β-cell function decline and incident type 2 diabetes: A longitudinal study 53
Different Patterns of Left Ventricular Hypertrophy in Metabolically Healthy and Insulin-Resistant Obese Subjects 52
Impaired insulin-stimulated myocardial glucose metabolic rate is associated with reduced estimated myocardial energetic efficiency in subjects with different degrees of glucose tolerance 51
The Functional Polymorphism of DDAH2 rs9267551 Is an Independent Determinant of Arterial Stiffness. 51
Association between augmented levels of the gut pro-hormone Proneurotensin and subclinical vascular damage 50
Sex-specific differences in left ventricular mass and myocardial energetic efficiency in non-diabetic, pre-diabetic and newly diagnosed type 2 diabetic subjects 50
Relationship between hemoglobin glycation index and myocardial mechano-energetic efficiency in non-diabetic individual 49
Anti-TNF therapy and plasma HDL cholesterol concentration (multiple letters) 49
Endothelial progenitor cells predict vascular damage progression in naive hypertensive patients according to sex 49
Predictors of renal function worsening in patients with chronic obstructive pulmonary disease (Copd): A multicenter observational study 49
Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes 49
Immuno-Mediated Inflammation in Hypertensive Patients with 1-h Post-Load Hyperglycemia 48
Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study 47
Low Insulin-Like Growth Factor-1 Levels Are Associated With Myocardial Mechano-Energetic Efficiency in Older Individuals 47
Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes 47
Competitive interaction between smoking and chronic obstructive pulmonary disease for explaining renal function reduction in hypertensive patients 47
Effects of continuous positive airway pressure on comprehensive geriatric assessment and cognitive function in elderly patients with obstructive sleep apnea syndrome 47
Serum γ-glutamyltransferase concentration predicts endothelial dysfunction in naive hypertensive patients 47
Endothelial dysfunction and C-reactive protein predict the incidence of heart failure in hypertensive patients 47
One Hour-Post-load Plasma Glucose ≥155 mg/dl in Healthy Glucose Normotolerant Subjects Is Associated With Subcortical Brain MRI Alterations and Impaired Cognition: A Pilot Study. 47
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 47
Association of sodium–glucose cotransporter 2 inhibitors with changes in comprehensive geriatric assessment in elderly diabetic patients with heart failure: Data from MAGIC-HF 46
Specific knockout of p85α in brown adipose tissue induces resistance to high-fat diet–induced obesity and its metabolic complications in male mice 46
COPD significantly increases cerebral and cardiovascular events in hypertensives 46
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 45
Whole blood viscosity is associated with reduced myocardial mechano-energetic efficiency in nondiabetic individuals. 45
Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life 2-year Follow-Up Study 45
Obese Patients With a Binge Eating Disorder Have an Unfavorable Metabolic and Inflammatory Profile 44
Prognostic role of serum albumin levels in patients with chronic heart failure 44
Oxidative Stress and Left Ventricular Performance in Patients with Different Glycometabolic Phenotypes 44
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register 43
One-hour post-load plasma glucose levels are associated with elevated liver enzymes 43
Association between non-dipping blood pressure pattern and different glucometabolic profile during oral glucose tolerance test 42
The Phosphatase PHLPP2 Plays a Key Role in the Regulation of Pancreatic Beta-Cell Survival 42
Ketogenic Diet-Induced Weight Loss is Associated with an Increase in Vitamin D Levels in Obese Adults. 42
Osteopontin levels correlate with severity of diabetic cardiomyopathy in early stage of diabetes 41
Frequency of prediabetes in individuals with increased adiposity and metabolically healthy or unhealthy phenotypes 41
Pharmacological treatment of type 2 diabetes in elderly patients with heart failure: randomized trials and beyond 41
Nox2 up-regulation and hypoalbuminemia in patients with type 2 diabetes mellitus 41
Higher serum levels of uric acid are associated with a reduced insulin clearance in non-diabetic individuals 40
Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetes 40
Guidelines for the screening and diagnosis of gestational diabetes in Italy from 2010 to 2019: critical issues and the potential for improvement 40
Effects of Alpha-2-HS-glycoprotein on cognitive and emotional assessment in prediabetic and diabetic subjects 40
One-hour post-load glucose is associated with severity of hepatic fibrosis risk 39
Pathophysiological characteristics of subjects with intermediate hyperglycemia and type 2 diabetes identified by 1-hour plasma glucose during an oral glucose tolerance test 39
Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells 39
Impaired Clinical Efficacy of Aspirin in Hypoalbuminemic Patients With Diabetes Mellitus 39
Nox2 up-regulation and hypoalbuminemia in patients with type 2 diabetes mellitus. 39
Short-term effect of sacubitril/valsartan on endothelial dysfunction and arterial stiffness in patients with chronic heart failure 38
Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes 38
Pioglitazone corrects dysregulation of skeletal muscle mitochondrial proteins involved in ATP synthesis in type 2 diabetes 38
Myocardial mechano‐energetic efficiency is not impaired in patients with metabolically healthy overweight and obesity 37
One-hour post-load hyperglycemia combined with HbA1c identifies pre-diabetic individuals with a higher cardio-metabolic risk burden 37
Short-term effect of sacubitril/valsartan on endothelial dysfunction and arterial stiffness in patients with chronic heart failure 37
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 37
Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes 37
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 37
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 36
Erratum. Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis. Diabetes Care 2021;44:1062–1069 36
Relationships of surrogate indexes of insulin resistance with insulin sensitivity assessed by euglycemic hyperinsulinemic clamp and subclinical vascular damage 35
Impaired Clinical Efficacy of Aspirin in Hypoalbuminemic Patients With Diabetes Mellitus. 35
The TRIB3 R84 variant is associated with increased left ventricular mass in a sample of 2426 White individuals. 35
Effects of Continuous Positive Airway Pressure Treatment on Vascular Function in a Real-Life Cohort of Elderly Patients with Obstructive Sleep Apnoea Syndrome 35
One-hour post-load glucose and subclinical left atrial myocardial dysfunction in hypertensive patients 35
Metabolic Syndrome Is Associated With Impaired Insulin-Stimulated Myocardial Glucose Metabolic Rate in Individuals With Type 2 Diabetes: A Cardiac Dynamic 18F-FDG-PET Study 34
Mean platelet volume (MPV) as new marker of diabetic macrovascular complications in patients with different glucose homeostasis 33
Totale 5.174
Categoria #
all - tutte 49.363
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.363


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 0 0 0 5 1 9
2021/2022191 0 1 4 23 22 5 20 35 24 23 34 0
2022/2023529 115 14 34 9 48 36 37 62 71 39 43 21
2023/2024485 86 70 26 47 44 76 16 11 10 16 37 46
2024/20251.448 168 14 32 34 120 171 140 64 168 33 208 296
2025/20263.099 218 351 367 522 364 141 388 147 392 209 0 0
Totale 5.893